SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.3500
+0.0150 (4.48%)
Sep 16, 2026, 2:50 PM AEST
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 76.92 million as of September 17, 2026. Its market cap has decreased by -51.71% in one year.
Market Cap
76.92M
Enterprise Value
65.19M
Revenue
114.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
ChartMarket Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 76.92M, an increase of 118.50%. That is a compound annual growth rate of 3.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 76.92M | -54.36% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EMVision Medical Devices | 160.35M |
| Lumos Diagnostics Holdings | 103.93M |
| Saluda Medical | 102.07M |
| Cyclopharm | 67.90M |
| Epiminder | 60.67M |
| Compumedics | 54.93M |
| Cleo Diagnostics | 42.50M |
| HeraMED | 38.24M |